Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69 A, Issue 2, 2014, Pages 189-198

  Althoff, Keri N ^a   Jacobson, Lisa P ^a   Cranston, Ross D ^b   Detels, Roger ^c   Phair, John P ^d   Li, Xiuhong ^a   Margolick, Joseph B ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Epidemiology; Frailty; Multimorbidities

Indexed keywords

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; EPIDEMIOLOGY; FATIGUE; FRAILTY; GAIT; HAND STRENGTH; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MALE HOMOSEXUALITY; MIDDLE AGED; MOTOR ACTIVITY; MULTIMORBIDITIES.; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RISK FACTOR; WEIGHT REDUCTION;

EPIDEMIOLOGY; FRAILTY; MULTIMORBIDITIES.;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; COHORT STUDIES; FATIGUE; GAIT; HAND STRENGTH; HEALTH STATUS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; RISK FACTORS; WEIGHT LOSS;

EID: 84896743037     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt148     Document Type: Article

References (50)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-860.
2. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293-299.
3. Prejean J, Song R, Hernandez A, et al. HIV Incidence Surveillance Group. Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011;6:e17502.
4. Centers for Disease Control and Prevention. HIV Surveillance Report, 2009. Atlanta, GA: Centers for Diesase Control and Prevention; 2011:21.
5. Luther VP, Wilkin AM. HIV infection in older adults. Clin Geriatr Med. 2007;23:567-83, vii.
6. Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci. 2006;61:262-266.
7. Fried LP, Tangen CM, Walston J, et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156.
8. Fried LP, Walston J. Frailty and failure to thrive. In: Hazzard WR, Blass JP, Ettinger WH, Halter JB, Ouslander J, eds. Principles of Geriatric Medicine and Gerontology. New York: McGraw Hill; 1998. 1387-1402.
9. Lipsitz LA. Physiological complexity, aging, and the path to frailty. Sci Aging Knowledge Environ. 2004;2004:pe16.
10. Kang HG, Costa MD, Priplata AA, et al. Frailty and the degradation of complex balance dynamics during a dual-task protocol. J Gerontol A Biol Sci Med Sci. 2009;64:1304-1311.
11. Fried LP, Xue QL, Cappola AR, et al. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci. 2009;64:1049-1057.
12. Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54:991-1001.
13. Paganelli R, Di Iorio A, Cherubini A, et al. Frailty of older age: the role of the endocrine-immune interaction. Curr Pharm Des. 2006;12:3147-3159.
14. Bortz W. Understanding frailty. J Gerontol A Biol Sci Med Sci. 2010;65:255-6; discussion 257.
15. Fried LP, Hadley EC, Walston JD, et al. From bedside to bench: research agenda for frailty. Sci Aging Knowledge Environ. 2005;2005:pe24.
16. Klein BE, Klein R, Knudtson MD, Lee KE. Frailty, morbidity and survival. Arch Gerontol Geriatr. 2005;41:141-149.
17. Cawthon PM, Marshall LM, Michael Y, et al. Osteoporotic Fractures in Men Research Group. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc. 2007;55:1216-1223.
18. Woods NF, La Croix AZ, Gray SL, et al. Women's Health Initiative. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc. 2005;53:1321-1330.
19. Ahmed N, Mandel R, Fain MJ. Frailty: an emerging geriatric syndrome. Am J Med. 2007;120:748-753.
20. Boyd CM, Xue QL, Simpson CF, Guralnik JM, Fried LP. Frailty, hospitalization, and progression of disability in a cohort of disabled older women. Am J Med. 2005;118:1225-1231.
21. Leone S, Gregis G, Quinzan G, et al. Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort. Infection. 2011;39:13-20.
22. Smith C, Sabin CA, Lundgren JD, et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS. 2010;24:1537-1548.
23. Marin B, Thiébaut R, Bucher HC, et al. Non-AIDS-defning deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS. 2009;23:1743-1753.
24. Pacheco AG, Tuboi SH, May SB, et al. Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr. 2009;51:624-630.
25. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397-406.
26. Desquilbet L, Jacobson LP, Fried LP, et al. Multicenter AIDS Cohort Study. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci. 2007;62:1279-1286.
27. Desquilbet L, Margolick JB, Fried LP, et al. Multicenter AIDS Cohort Study. Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr. 2009;50:299-306.
28. Desquilbet L, Jacobson LP, Fried LP, et al. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci. 2011;66:1030-1038.
29. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
30. Bing EG, Hays RD, Jacobson LP, et al. Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study. Qual Life Res. 2000;9:55-63.
31. Radloff LS. A self-reported depression scale for research in the general population. Appl Psychol Measurement. 1997;1:385-401.
32. Jacobson LP, Phair JP, Yamashita TE. Update on the Virologic and Immunologic Response to Highly Active Antiretroviral Therapy. Curr Infect Dis Rep. 2004;6:325-332.
33. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol. 1987;126:310-318.
34. Dudley J, Jin S, Hoover D, Metz S, Thackeray R, Chmiel J. The Multicenter AIDS Cohort Study: retention after 9 1/2 years. Am J Epidemiol. 1995;142:323-330.
35. Detels R, Jacobson L, Margolick J, et al. The multicenter AIDS Cohort Study, 1983 to ⋯. Public health. 2012;126:196-198.
36. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
37. Hultin LE, Menendez FA, Hultin PM, et al. Assessing immunophenotyping performance: proficiency-validation for adopting improved fow cytometry methods. Cytometry B Clin Cytom. 2007;72:249-255.
38. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. http://aidsinfo.nih.gov/contentfiles/ lvguidelines/adultandadolescentgl.pdf. Accessed September 3, 2013.
39. 1993 revised classification system for HIV infection and expanded surveillance case defnition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41:1-19.
40. Zeger SL, Liang K Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
41. Onen NF, Agbebi A, Shacham E, Stamm KE, Onen AR, Overton ET. Frailty among HIV-infected persons in an urban outpatient care setting. J Infect. 2009;59:346-352.
42. Ferris D, Zhang C, Dam T, et al. Frailty rate in HIV+ mid-50 women matches rate in 70-year-olds without HIV. 6th IAS Conference on Pathogensis, Treatment and Prevention, 2011.
43. Terzian AS, Holman S, Nathwani N, et al. Women's Interagency HIV Study. Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART. J Womens health (Larchmt). 2009;18:1965-1974.
44. Piggott DA, Muzaale AD, Mehta SH, et al. Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS One. 2013;8:e54910.
45. Pathai S, Gilbert C, Weiss HA, et al. Frailty in HIV-infected adults in South Africa. J Acquir Immune Defic Syndr. 2012;253:37-42.
46. Martin J, Volberding P. HIV and premature aging: A feld still in its infancy. Ann Intern Med. 2010;153:477-479.
47. Ianas V, Berg E, Mohler MJ, Wendel C, Klotz SA. Antiretroviral therapy protects against frailty in HIV-1 infection. J Int Assoc Provid AIDS Care. 2013;12:62-66.
48. Gill TM, Gahbauer EA, Allore HG, Han L. Transitions between frailty states among community-living older persons. Arch Intern Med. 2006;166:418-423.
49. Xue QL. The frailty syndrome: defnition and natural history. Clin Geriatr Med. 2011;27:1-15.
50. Morgan EE, Iudicello JE, Weber E, et al. HIV Neurobehavioral Research Program (HNRP) Group. Synergistic effects of HIV infection and older age on daily functioning. J Acquir Immune Defic Syndr. 2012;61:341-348.